SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech vs. Shorts
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (375)2/26/2000 12:35:00 PM
From: Biotech Jim  Read Replies (1) of 427
 
Peter, good find, the following from Herb Greenberg I found the most interesting as to those interested in potentially shorting biotechs:

<Which leads to hard-knock lesson No. 1: Be careful of shorting industries in which the public is essentially providing venture capital. Cash, after all, is king. If the industry gets momentum, access to capital may be greater than even its most fanatic fans believe. And with enough capital, many an industry can do more than merely get off the ground.>

There still remains lots of capital to come into this sector. I hear that the investment bankers are really doing a push now for secondaries. They have a lot of $ lined up.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News